References
Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E (2009) Multidisciplinary management of Hunter syndrome. Pediatrics 124(6):1228–1239. doi:10.1542/peds.2008-0999
Dogan M, Cesur Y, Peker E, Oner AF, Dogan SZ (2010) Thrombocytopenia associated with galsulfase treatment. Hum Exp Toxicol. doi:10.1177/0960327110379023
Jadin L, Wu X, Ding H, Frost GI, Onclinx C, Triggs-Raine B, Flamion B (2008) Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX? FASEB J 22:4316–4326. doi:10.1096/fj.08-111997
Case DB, Whitman H, Laragh JM, Spiera H (1981) Successful low dose captopril rechallenge following drug-induced leucopenia. Lancet 1:1362–1363
Grosbois B, Milton D, Beneton C, Jacomy D (1989) Thrombocytopenia induced by angiotensin converting enzyme inhibitors. BMJ 298:189–190
Walsh KP, Branagan J, Walsh MJ (1986) Reversible severe thrombocytopenia associated with captopril therapy. Ir Med J 79:43–44
Khan MA, Bashi SA, Noah MS (1987) Captopril associated isolated thrombocytopenia. Ir Med J 80:101
Toltl LJ, Arnold DM (2011) Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. Br J Haematol 152:52–60. doi:10.1111/j.1365-2141.2010.08412.x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uz, B., Demiroglu, H. & Ozcebe, O.I. Hunter syndrome and new onset idiopathic thrombocytopenic purpura in a young patient. Ann Hematol 91, 303–304 (2012). https://doi.org/10.1007/s00277-011-1248-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-011-1248-6